While no differences in UBQLN4 solubility were detected in PD, DLB or PSP samples compared to age-matched controls, our limited analysis of available human samples does not allow us to conclude that there are no disease-dependent changes. This evidence concerns the gene UBQLN4 and supranuclear palsy, progressive, 1.